GlassScriptPhysician profile
Donnell I James
NPI 1407163439
$14,799.82
in general payments reported to CMS, 2019-2025
53 companies · $3,440 in 2025
The $3,440 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,426 · 2022: $2,197 · 2023: $2,994 · 2024: $2,743 · 2025: $3,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,083 · Education: $93.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,082.86 |
| Education | $93.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,221.68 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $1,416.63 | 2021 | |
| Novo Nordisk INC | $1,410.23 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $1,086.07 | 2021-2025 | |
| Lilly USA, LLC | $938.09 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $838.56 | 2021-2025 | Repatha, Otezla, Krystexxa |
| Bausch Health US, LLC | $785.09 | 2021-2025 | Aplenzin, Wellbutrin |
| Boehringer Ingelheim Pharmaceuticals, INC. | $608.38 | 2021-2025 | Jardiance, Ofev |
| Corium, LLC | $563.33 | 2022-2025 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $533.22 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Lundbeck LLC | $422.74 | 2021-2025 | Rexulti, Vyepti |
| Exact Sciences Corporation | $402.56 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $306.18 | 2022-2025 | Shingrix, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $290.57 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Astellas Pharma US INC | $249.19 | 2021-2025 | Veozah |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donnell James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.